PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsThromboprophylaxis
Thromboprophylaxis
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
179 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ThromboembolismD013923HP_0001907—3815173575
Venous thromboembolismD054556EFO_0004286I743914123065
ThrombosisD013927———51362950
Venous thrombosisD020246HP_0004936I82.4015632234
Covid-19D000086382——15101924
EmbolismD004617——43341324
Pulmonary embolismD011655HP_0002204I2643241323
HemorrhageD006470MP_0001914R58———4711
Wounds and injuriesD014947—T14.8—22127
Multiple myelomaD009101—C90.0—12136
Show 22 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369—C80—14—49
Postoperative complicationsD011183————1—56
Hip fracturesD006620EFO_0003964S72.00—14——5
Female genital neoplasmsD005833———11—24
ThrombophiliaD019851—D68.59——1—34
SyndromeD013577———12—13
ObesityD009765EFO_0001073E66.91—1—13
Leg injuriesD007869————1—23
Colorectal neoplasmsD015179————1—23
Blood coagulationD001777GO_0007596———1—23
Show 16 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Morbid obesityD009767EFO_0001074—31——14
Ovarian neoplasmsD010051EFO_0003893C56—2——13
Virus diseasesD014777—B3411———2
Myeloproliferative disordersD009196—D47.1—1———1
Essential thrombocythemiaD013920—D47.3—1———1
Polycythemia veraD011087—D45—1———1
Primary myelofibrosisD055728—D47.4—1———1
ThrombocytosisD013922HP_0001894D75.83—1———1
PolycythemiaD011086EFO_0005804D75.1—1———1
Spinal cord injuriesD013119EFO_1001919——1———1
Show 11 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PregnancyD011247EFO_0002950Z33.11———34
Ulcerative colitisD003093EFO_0000729K511————1
Crohn diseaseD003424EFO_0000384K501————1
Inflammatory bowel diseasesD015212EFO_0003767—1————1
Cesarean sectionD002585——1————1
Sars-cov-2D000086402——1————1
Healthy volunteers/patients———1————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Atrial fibrillationD001281EFO_0000275I48.0————44
Fetal deathD005313HP_0003826—————22
Intracranial hemorrhagesD020300EFO_0000551I62————22
Traumatic intracranial hemorrhageD020198——————22
Pelvic organ prolapseD056887EFO_0004710—————22
Urinary incontinenceD014549HP_0000020R32————22
ProlapseD011391——————22
HospitalizationD006760——————22
Atrial flutterD001282EFO_0003911—————11
Spontaneous abortionD000022EFO_1001255O00.1————11
Show 39 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use